(Q48118239)

8 February 2018

title

Levetiracetam use in critically ill patients (English)

1 reference

8 February 2018

1 reference

4

1 reference

8 February 2018

Magdalena Szaflarski

object named as

Magdalena Szaflarski

3

0 references

Jerzy P Szaflarski

1

object named as

Jerzy P Szaflarski

1 reference

8 February 2018

author name string

Jason M Meckler

2

1 reference

8 February 2018

Michael D Privitera

5

1 reference

8 February 2018

Stephen L Yates

6

1 reference

8 February 2018

publication date

1 January 2007

1 reference

8 February 2018

published in

Neurocritical Care

1 reference

8 February 2018

volume

7

1 reference

8 February 2018

issue

2

1 reference

8 February 2018

page(s)

140-147

1 reference

8 February 2018

https://scigraph.springernature.com/pub.10.1007/s12028-007-0042-8

exact match

0 references

cites work

Discontinuation of levetiracetam because of behavioral side effects: a case-control study

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12028-007-0042-8

Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia

21 January 2018

1 reference

12 December 2020

Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy

1 reference

12 December 2020

The effect of race and sex on physicians' recommendations for cardiac catheterization

1 reference

12 December 2020

Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage

1 reference

12 December 2020

Levetiracetam: preliminary experience in patients with primary brain tumours

1 reference

12 December 2020

Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group

1 reference

12 December 2020

Neurobehavioral effects of phenytoin prophylaxis of posttraumatic seizures

1 reference

12 December 2020

Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy

1 reference

12 December 2020

Pharmacogenomics: translating functional genomics into rational therapeutics

1 reference

12 December 2020

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy

1 reference

12 December 2020

Levetiracetam in the treatment of status epilepticus in adults: a study of 13 episodes

1 reference

12 December 2020

A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy

1 reference

12 December 2020

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy

1 reference

12 December 2020

Use of levetiracetam in a population of patients aged 65 years and older: a subset analysis of the KEEPER trial

1 reference

12 December 2020

Epilepsy in the elderly

1 reference

12 December 2020

Racial and ethnic disparities in emergency department analgesic prescription

1 reference

12 December 2020

A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy

1 reference

12 December 2020

Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy

1 reference

12 December 2020

A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.

1 reference

12 December 2020

Optimal seizure management in brain tumor patients

1 reference

12 December 2020

New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine

1 reference

12 December 2020

Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group

1 reference

12 December 2020

Pharmacokinetic profile of levetiracetam: toward ideal characteristics

1 reference

12 December 2020

Rapid onset of action of levetiracetam in refractory epilepsy patients

1 reference

12 December 2020

The new antiepileptic drugs: clinical applications.

1 reference

12 December 2020

The use of levetiracetam in refractory status epilepticus

1 reference

12 December 2020

Evidence for a rapid action of levetiracetam compared to topiramate in refractory partial epilepsy

1 reference

12 December 2020

Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial

1 reference

12 December 2020

A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials.

1 reference

12 December 2020

Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia

1 reference

12 December 2020

Gabapentin to control seizures in children undergoing cancer treatment

1 reference

12 December 2020

Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia

1 reference

12 December 2020

The new antiepileptic drugs: scientific review

1 reference

12 December 2020

Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 mild to severe cases

1 reference

12 December 2020

Rationing in the intensive care unit.

1 reference

12 December 2020

10.1007/S12028-007-0042-8

Identifiers

DOI

1 reference

8 February 2018

1 reference

8 February 2018